U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
PERTUZUMAB
K16AIQ8CTM
US Approved Rx (2012)
First approved in 2012
General
Names
17
Classification
6
Identifiers
19
Subunits
4
Related Substances
1
PERTUZUMAB
K16AIQ8CTM
US Approved Rx (2012)
First approved in 2012
General
Approval Year
2012
608
Names
17
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
PERTUZUMAB
Official Name
English
PERTUZUMAB (GENETICAL RECOMBINATION)
Preferred Name
English
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Common Name
English
RHUMAB-2C4
Code
English
PERTUZUMAB [VANDF]
Common Name
English
Showing 1 to 5 of 17 entries
Previous
1
2
3
4
Next
Classification
6
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of ovarian cancer
FDA ORPHAN DRUG
284409
Monoclonal antibodies
VATC
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
Monoclonal antibodies
pertuzumab
WHO-VATC
QL01XC13
Monoclonal Antibody
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
[C20401]
Anti-HER2 Monoclonal Antibody
NCI_THESAURUS
C155711
Monoclonal antibodies
ATC
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
Monoclonal antibodies
pertuzumab
WHO-ATC
L01XC13
Established Pharmacologic Class
Established Pharmacologic Class
[EPC]
HER2/neu Receptor Antagonist
[EPC]
NDF-RT
N0000175661
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Identifiers
19
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
INN
8380
PRIMARY
LACTMED
Pertuzumab
PRIMARY
DRUG CENTRAL
4957
PRIMARY
JAPANESE REVIEW
PERJETA
PRIMARY
APPROVED JUNE 2013
SMS_ID
100000078567
PRIMARY
Showing 1 to 5 of 19 entries
Previous
1
2
3
4
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
K16AIQ8CTM
PERTUZUMAB
